New insights into the pathogenesis of alcohol-induced ER stress and liver diseases

International Journal of Hepatology

Volumn 2014, Issue , 2014, Pages

  Ji, Cheng ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETALDEHYDE; ACTIVATING TRANSCRIPTION FACTOR 4; BETA CATENIN; CALCIUM; CYCLIN D; CYCLIN DEPENDENT KINASE; CYTOCHROME P450 2E1; ESTROGEN RECEPTOR ALPHA; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HOMOCYSTEINE; INITIATION FACTOR 2ALPHA; INTERLEUKIN 6; LIVER PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR FKHRL1; TRIACYLGLYCEROL;

ALCOHOL CONSUMPTION; ALCOHOL INDUCED LIVER DISEASE; ALCOHOLIC FATTY LIVER; ALCOHOLISM; BREAST CANCER; CALCIUM HOMEOSTASIS; CARBON METABOLISM; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL PROLIFERATION; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; INSULIN RESISTANCE; INTROSPECTION; LIVER CANCER; LIVER CELL; LIVER DISEASE; LIVER INJURY; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; REVIEW; SIGNAL TRANSDUCTION; STOMACH CANCER;

EID: 84921471607     PISSN: 20903448     EISSN: 20903456     Source Type: Journal    
DOI: 10.1155/2014/513787     Document Type: Review

References (125)

1. Walter P., Ron D., The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011 334 6059 1081 1086 2-s2.0-82255173966 10.1126/science.1209038
2. Cao S. S., Kaufman R. J., Targeting endoplasmic reticulum stress in metabolic disease. Expert Opinion on Therapeutic Targets 2013 17 4 437 448
3. Fu S., Watkins S. M., Hotamisligil G. S., The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metabolism 2012 15 5 623 634 2-s2.0-84860483727 10.1016/j.cmet.2012.03.007
4. Henkel A., Green R. M., The unfolded protein response in Fatty liver disease. Seminars in Liver Disease 2013 33 4 321 329
5. Wolff S., Weissman J. S., Dillin A., Differential scales of protein quality control. Cell 2014 157 1 52 64
6. Ozcan L., Tabas I., Role of endoplasmic reticulum stress in metabolic disease and other disorders. Annual Review of Medicine 2012 63 317 328 2-s2.0-84855966721 10.1146/annurev-med-043010-144749
7. Kitamura M., The unfolded protein response triggered by environmental factors. Seminars in Immunopathology 2013 35 3 259 275
8. Ji C., Dissection of endoplasmic reticulum stress signaling in alcoholic and non-alcoholic liver injury. Journal of Gastroenterology and Hepatology 2008 23 1 S16 S24 2-s2.0-40749083206 10.1111/j.1440-1746.2007.05276.x (Pubitemid 351389024)
9. Ji C., Mechanisms of alcohol-induced endoplasmic reticulum stress and organ injuries. Biochemistry Research International 2012 2012 12 2-s2.0-84855281868 10.1155/2012/216450 216450
10. Kaphalia L., Boroumand N., Hyunsu J., Kaphalia B. S., Calhoun W. J., Ethanol metabolism, oxidative stress, and endoplasmic reticulum stress responses in the lungs of hepatic alcohol dehydrogenase deficient deer mice after chronic ethanol feeding. Toxicology and Applied Pharmacology 2014 10.1016/j.taap.2014. 02.018
11. Ji C., Kaplowitz N., Betaine decreases hyperhomocysteinemia, endoplasmic reticulum stress, and liver injury in alcohol-fed mice. Gastroenterology 2003 124 5 1488 1499 2-s2.0-0037960128 10.1016/S0016-5085(03)00276-2 (Pubitemid 36531821)
12. Ji C., Chan C., Kaplowitz N., Predominant role of sterol response element binding proteins (SREBP) lipogenic pathways in hepatic steatosis in the murine intragastric ethanol feeding model. Journal of Hepatology 2006 45 5 717 724 2-s2.0-33749253713 10.1016/j.jhep.2006.05.009 (Pubitemid 44479875)
13. Ji C., Mehrian-Shai R., Chan C., Hsu Y.-H., Kaplowitz N., Role of CHOP in hepatic apoptosis in the murine model of intragastric ethanol feeding. Alcoholism: Clinical and Experimental Research 2005 29 8 1496 1503 2-s2.0-24144472287 10.1097/01.alc.0000174691.03751.11 (Pubitemid 41243375)
14. Ji C., Shinohara M., Kuhlenkamp J., Chan C., Kaplowitz N., Mechanisms of protection by the betaine-homocysteine methyltransferase/ betaine system in HepG2 cells and primary mouse hepatocytes. Hepatology 2007 46 5 1586 1596 2-s2.0-36349032213 10.1002/hep.21854 (Pubitemid 350155540)
15. Ji C., Shinohara M., Vance D., Than T. A., Ookhtens M., Chan C., Kaplowitz N., Effect of transgenic extrahepatic expression of betaine-homocysteine methyltransferase on alcohol or homocysteine-induced fatty liver. Alcoholism: Clinical and Experimental Research 2008 32 6 1049 1058 2-s2.0-44349124501 10.1111/j.1530-0277.2008.00666.x (Pubitemid 351733088)
16. Xu J., Lai K. K. Y., Verlinsky A., Lugea A., French S. W., Cooper M. P., Ji C., Tsukamoto H., Synergistic steatohepatitis by moderate obesity and alcohol in mice despite increased adiponectin and p-AMPK. Journal of Hepatology 2011 55 3 673 682 2-s2.0-84860389258 10.1016/j.jhep.2010.12.034
17. Shinohara M., Ji C., Kaplowitz N., Differences in betaine-homocysteine methyltransferase expression, endoplasmic reticulum stress response, and liver injury between alcohol-fed mice and rats. Hepatology 2010 51 3 796 805 2-s2.0-77950612408 10.1002/hep.23391
18. Tsuchiya M., Ji C., Kosyk O., Shymonyak S., Melnyk S., Kono H., Tryndyak V., Muskhelishvili L., Pogribny I. P., Kaplowitz N., Rusyn I., Interstrain differences in liver injury and one-carbon metabolism in alcohol-fed mice. Hepatology 2012 56 1 130 139
19. Ronis M. J., Korourian S., Blackburn M. L., Badeaux J., Badger T. M., The role of ethanol metabolism in development of alcoholic steatohepatitis in the rat. Alcohol 2010 44 2 157 169 2-s2.0-77249093012 10.1016/j.alcohol.2009.11.002
20. Esfandiari F., Medici V., Wong D. H., Jose S., Dolatshahi M., Quinlivan E., Dayal S., Lentz S. R., Tsukamoto H., Zhang Y. H., French S. W., Halsted C. H., Epigenetic regulation of hepatic endoplasmic reticulum stress pathways in the ethanol-fed cystathionine beta synthase-deficient mouse. Hepatology 2010 51 3 932 941 2-s2.0-77950622833 10.1002/hep.23382
21. Esfandiari F., Villanueva J. A., Wong D. H., French S. W., Halsted C. H., Chronic ethanol feeding and folate deficiency activate hepatic endoplasmic reticulum stress pathway in micropigs. American Journal of Physiology- Gastrointestinal and Liver Physiology 2005 289 1 G54 G63 2-s2.0-21744436422 10.1152/ajpgi.00542.2004 (Pubitemid 40944223)
22. Ji C., Kaplowitz N., Lau M. Y., Kao E., Petrovic L. M., Lee A. S., Liver-specific loss of glucose-regulated protein 78 perturbs the unfolded protein response and exacerbates a spectrum of liver diseases in mice. Hepatology 2011 54 1 229 239 2-s2.0-79959544189 10.1002/hep.24368
23. Fernandez A., Matias N., Fucho R., ASMase is required for chronic alcohol induced hepaticendoplasmic reticulum stress and mitochondrial cholesterol loading. Journal of Hepatology 2013 59 4 805 813
24. Tan T. C., Crawford D. H., Jaskowski L. A., Subramaniam V. N., Clouston A. D., Crane D. I., Bridle K. R., Anderson G. J., Fletcher L. M., Excess iron modulates endoplasmic reticulum stress-associated pathways in a mouse model of alcohol and high-fat diet-induced liver injury. Laboratory Investigation 2013 93 12 1295 1312
25. Tan T. C., Crawford D. H., Jaskowski L. A., Murphy T. L., Santrampurwala N., Crane D., Clouston A. D., Subramaniam V. N., Anderson G. J., Fletcher L. M., A corn oil-based diet protects against combined ethanol and iron-induced liver injury in a mouse model of hemochromatosis. Alcoholism: Clinical and Experimental Research 2013 37 10 1619 1631
26. Galligan J. J., Smathers R. L., Fritz K. S., Epperson L. E., Hunter L. E., Petersen D. R., Protein carbonylation in a murine model for early alcoholic liver disease. Chemical Research in Toxicology 2012 25 5 1012 1021
27. Galligan J. J., Smathers R. L., Shearn C. T., Fritz K. S., Backos D. S., Jiang H., Franklin C. C., Orlicky D. J., Maclean K. N., Petersen D. R., Oxidative stress and the ER stress response in a murine model for early-stage alcoholic liver disease. Journal of Toxicology 2012 2012 12 207594 10.1155/2012/207594
28. Nishitani Y., Matsumoto H., Ethanol rapidly causes activation of JNK associated with ER stress under inhibition of ADH. FEBS Letters 2006 580 1 9 14 2-s2.0-29344468246 10.1016/j.febslet.2005.11.030 (Pubitemid 43005304)
29. Kao E., Shinohara M., Feng M., Lau M. Y., Ji C., Human immunodeficiency virus protease inhibitors modulate Ca(2+) homeostasis and potentiate alcoholic stress and injury in mice and primary mouse and human hepatocytes. Hepatology 2012 56 2 594 604
30. Tazi K. A., Bièche I., Paradis V., Guichard C., Laurendeau I., Dargère D., Legrand A., Fay M., Pedruzzi E., Robin M.-A., Cazals-Hatem D., Tellier Z., Bernuau D., Feldmann G., Vidaud M., Lebrec D., Ogier-Denis E., Moreau R., In vivo altered unfolded protein response and apoptosis in livers from lipopolysaccharide-challenged cirrhotic rats. Journal of Hepatology 2007 46 6 1075 1088 2-s2.0-34247585054 10.1016/j.jhep.2007.01.034 (Pubitemid 46680360)
31. Petrasek J., Iracheta-Vellve A., Csak T., Satishchandran A., Kodys K., Kurt-Jones E. A., Fitzgerald K. A., Szabo G., STING-IRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease. Proceedings of the National Academy of Sciences of the United States of America 2013 110 41 16544 16549
32. Passeri M. J., Cinaroglu A., Gao C., Sadler K. C., Hepatic steatosis in response to acute alcohol exposure in zebrafish requires sterol regulatory element binding protein activation. Hepatology 2009 49 2 443 452 2-s2.0-61949349873 10.1002/hep.22667
33. Thakur P. C., Stuckenholz C., Rivera M. R., Davison J. M., Yao J. K., Amsterdam A., Sadler K. C., Bahary N., Lack of de novo phosphatidylinositol synthesis leads to endoplasmic reticulum stress and hepatic steatosis in cdipt-deficient zebrafish. Hepatology 2011 54 2 452 462 2-s2.0-79960739850 10.1002/hep.24349
34. Tsedensodnom O., Vacaru A. M., Howarth D. L., Yin C., Sadler K. C., Ethanol metabolism and oxidative stress are required for unfolded protein response activation and steatosis in zebrafish with alcoholic liver disease. Disease Models & Mechanisms 2013 6 5 1213 1226
35. Ient B., Edwards R., Mould R., Hannah M., Holden-Dye L., O'Connor V., HSP-4 endoplasmic reticulum (ER) stress pathway is not activated in a C. elegans model of ethanol intoxication and withdrawal. Invertebrate Neuroscience 2012 12 2 93 102
36. Boukli N. M., Saiyed Z. M., Ricaurte M., Rodriguez J. W., Ríos Olivares E., Cubano L. A., Nair M. P. N., Implications of ER stress, the unfolded protein response, and pro- and anti-apoptotic protein fingerprints in human monocyte-derived dendritic cells treated with alcohol. Alcoholism: Clinical and Experimental Research 2010 34 12 2081 2088 2-s2.0-78649596663 10.1111/j.1530-0277.2010.01304.x
37. Magne L., Blanc E., Legrand B., Lucas D., Barouki R., Rouach H., Garlatti M., ATF4 and the integrated stress response are induced by ethanol and cytochrome P450 2E1 in human hepatocytes. Journal of Hepatology 2011 54 4 729 737 2-s2.0-79952698822 10.1016/j.jhep.2010.07.023
38. Howarth D. L., Vacaru A. M., Tsedensodnom O., Mormone E., Nieto N., Costantini L. M., Snapp E. L., Sadler K. C., Alcohol disrupts endoplasmic reticulum function and protein secretion in hepatocytes. Alcoholism: Clinical and Experimental Research 2012 36 1 14 23 2-s2.0-84855305763 10.1111/j.1530-0277.2011.01602.x
39. Longato L., Ripp K., Setshedi M., Insulin resistance, ceramide accumulation, and endoplasmic reticulum stress in human chronic alcohol-related liver disease. Oxidative Medicine and Cellular Longevity 2012 2012 17 479348 10.1155/2012/479348
40. Ramirez T., Longato L., Dostalek M., Tong M., Wands J. R., de la Monte S. M., Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis. Alcohol and Alcoholism 2013 48 1 39 52
41. Ramirez T., Tong M., Chen W. C., Nguyen Q. G., Wands J. R., de la Monte S. M., Chronic alcohol-induced hepatic insulin resistance and ER stress ameliorated by PPAR- δ agonist treatment. Journal of Gastroenterology and Hepatology 2013 28 1 179 187
42. Tong M., Longato L., Ramirez T., Zabala V., Wands J. R., de la Monte S. M., Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin. International Journal of Experimental Pathology 2014 95 1 49 63
43. Cinti D. L., Grundin R., Orrenius S., The effect of ethanol on drug oxidations in vitro and the significance of ethanol-cytochrome P-450 interaction. Biochemical Journal 1973 134 2 367 375
44. Lieber C. S., Microsomal ethanol-oxidizing system. Enzyme 1987 37 1-2 45 56 2-s2.0-0023098926 (Pubitemid 17011713)
45. Lieber C. S., The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metabolism Reviews 2004 36 3-4 511 529 2-s2.0-7544222395 10.1081/DMR-200033441 (Pubitemid 39453060)
46. Lieber C. S., Pathogenesis and treatment of alcoholic liver disease: progress over the last 50 years. Roczniki Akademii Medycznej w Białymstoku 2005 50 7 20 2-s2.0-33644826328
47. Barak A. J., Beckenhauer H. C., Tuma D. J., Badakhsh S., Effects of prolonged ethanol feeding on methionine metabolism in rat liver. Biochemistry and Cell Biology 1987 65 3 230 233 2-s2.0-0023091198 (Pubitemid 17055279)
48. Blasco C., Caballería J., Deulofeu R., Lligoña A., Parés A., Lluis J. M., Gual A., Rodés J., Prevalence and mechanisms of hyperhomocysteinemia in chronic alcoholics. Alcoholism: Clinical and Experimental Research 2005 29 6 1044 1048 (Pubitemid 40934209)
49. Hultberg B., Berglund M., Andersson A., Frank A., Elevated plasma homocysteine in alcoholics. Alcoholism: Clinical and Experimental Research 1993 17 3 687 689 2-s2.0-0027231298 (Pubitemid 23178459)
50. Lutz U. C., Alterations in homocysteine metabolism among alcohol dependent patients-clinical, pathobiochemical and genetic aspects. Current Drug Abuse Reviews 2008 1 1 47 55 2-s2.0-68549101818
51. Bleich S., Lenz B., Ziegenbein M., Beutler S., Frieling H., Kornhuber J., Bönsch D., Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. Alcoholism: Clinical and Experimental Research 2006 30 4 587 591 2-s2.0-33645368048 10.1111/j.1530-0277.2006.00068.x
52. Win S., Than T. A., Fernandez-Checa J. C., Kaplowitz N., JNK interaction with Sab mediates ER stress induced inhibition of mitochondrial respiration and cell death. Cell Death & Disease 2014 5, article e989 10.1038/cddis.2013.522
53. Han D., Ybanez M. D., Johnson H. S., McDonald J. N., Mesropyan L., Sancheti H., Martin G., Martin A., Lim A. M., Dara L., Cadenas E., Tsukamoto H., Kaplowitz N., Dynamic adaptation of liver mitochondria to chronic alcohol feeding in mice: biogenesis, remodeling, and functional alterations. The Journal of Biological Chemistry 2012 287 50 42165 42179
54. Inokuchi S., Tsukamoto H., Park E., Liu Z.-X., Brenner D. A., Seki E., Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcoholism: Clinical and Experimental Research 2011 35 8 1509 1518 2-s2.0-79959811718 10.1111/j.1530-0277.2011.01487.x
55. Vandewynckel Y. P., Laukens D., Geerts A., Bogaerts E., Paridaens A., Verhelst X., Janssens S., Heindryckx F., van Vlierberghe H., The paradox of the unfolded protein response in cancer. Anticancer Research 2013 33 11 4683 4694
56. Wang W. A., Groenendyk J., Michalak M., Endoplasmic reticulum stress associated responses in cancer. Biochimica et Biophysica Acta 2014 10.1016/j.bbamcr.2014.01.012
57. Brown J. M., Giaccia A. J., The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Research 1998 58 7 1408 1416 2-s2.0-0032053823 (Pubitemid 28193601)
58. Giaccia A. J., Brown J. M., Wouters B., Denko N., Koumenis C., Cancer therapy and tumor physiology. Science 1998 279 5347 12 13 2-s2.0-0032472232
59. Lee A. S., Glucose-regulated proteins in cancer: molecular mechanisms and therapeutic potential. Nature Reviews Cancer 2014 14 4 263 276
60. Weston R. T., Puthalakath H., Endoplasmic reticulum stress and BCL-2 family members. Advances in Experimental Medicine and Biology 2010 687 65 77 2-s2.0-77958132334 10.1007/978-1-4419-6706-0-4
61. Wang C., Jiang K., Gao D., Clusterin protects hepatocellular carcinoma cells from endoplasmic reticulum stress induced apoptosis through GRP78. PLoS One 2013 8 2, article e55981
62. Martinon F., Targeting endoplasmic reticulum signaling pathways in cancer. Acta Oncologica 2012 51 7 822 830
63. Koumenis C., ER stress, hypoxia tolerance and tumor progression. Current Molecular Medicine 2006 6 1 55 69 2-s2.0-33646167400 10.2174/156652406775574604
64. Fels D. R., Koumenis C., The PERK/eIF2alpha/ATF4 module of the UPR in hypoxia resistance and tumor growth. Cancer Biology & Therapy 2006 5 7 723 728 (Pubitemid 44794028)
65. Blais J. D., Addison C. L., Edge R., Falls T., Zhao H., Wary K., Koumenis C., Harding H. P., Ron D., Holcik M., Bell J. C., Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress. Molecular and Cellular Biology 2006 26 24 9517 9532 2-s2.0-33845465578 10.1128/MCB.01145-06 (Pubitemid 44904443)
66. Rzymski T., Milani M., Pike L., Buffa F., Mellor H. R., Winchester L., Pires I., Hammond E., Ragoussis I., Harris A. L., Regulation of autophagy by ATF4 in response to severe hypoxia. Oncogene 2010 29 31 4424 4435 2-s2.0-77955467319 10.1038/onc.2010.191
67. Cojocari D., Vellanki R. N., Sit B., Uehling D., Koritzinsky M., Wouters B. G., New small molecule inhibitors of UPR activation demonstrate that PERK, but not IRE1 α signaling is essential for promoting adaptation and survival to hypoxia. Radiotherapy & Oncology 2013 108 3 541 547
68. Schewe D. M., Aguirre-Ghiso J. A., ATF6 α -Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo. Proceedings of the National Academy of Sciences of the United States of America 2008 105 30 10519 10524 2-s2.0-48749105093 10.1073/pnas.0800939105
69. Hetz C., Bernasconi P., Fisher J., Lee A.-H., Bassik M. C., Antonsson B., Brandt G. S., Iwakoshi N. N., Schrinzel A., Glimcher L. H., Korsmeyer S. J., Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1 α Science 2006 312 5773 572 576 2-s2.0-33646237823 10.1126/science.1123480
70. Rodriguez D. A., Zamorano S., Lisbona F., Rojas-Rivera D., Urra H., Cubillos-Ruiz J. R., Armisen R., Henriquez D. R., H Cheng E., Letek M., Vaisar T., Irrazabal T., Gonzalez-Billault C., Letai A., Pimentel-Muiños F. X., Kroemer G., Hetz C., BH3-only proteins are part of a regulatory network that control the sustained signalling of the unfolded protein response sensor IRE1 α EMBO Journal 2012 31 10 2235 2437 2-s2.0-84859729476 10.1038/emboj.2012.84
71. Vilner B. J., De Costa B. R., Bowen W. D., Cytotoxic effects of sigma ligands: sigma receptor-mediated alterations in cellular morphology and viability. Journal of Neuroscience 1995 15 1, part 1 117 134 2-s2.0-0028876578
72. Hayashi T., Su T.-P., Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival. Cell 2007 131 3 596 610 2-s2.0-35549006797 10.1016/j.cell.2007.08.036 (Pubitemid 350017760)
73. Grewal P., Viswanathen V. A., Liver cancer and alcohol. Clinical Liver Disease 2012 16 4 839 850
74. Warren K. R., Murray M. M., Alcoholic liver disease and pancreatitis: global health problems being addressed by the US National Institute on Alcohol Abuse and Alcoholism. Journal of Gastroenterology and Hepatology 2013 28 supplement 1 4 6
75. Friedmann P. D., Alcohol use in adults. The New England Journal of Medicine 2013 368 17 1655 1656
76. Gunzerath L., Hewitt B. G., Li T.-K., Warren K. R., Alcohol research: past, present, and future. Annals of the New York Academy of Sciences 2011 1216 1 1 23 2-s2.0-79251494740 10.1111/j.1749-6632.2010.05832.x
77. Zhu X., Zhang J., Fan W., The rs391957 variant cis-regulating oncogene GRP78 expression contributes to the risk of hepatocellular carcinoma. Carcinogenesis 2013 34 6 1273 1280
78. Winder T., Bohanes P., Zhang W., Yang D., Power D. G., Ning Y., Gerger A., Wilson P. M., Tang L. H., Shah M., Lee A. S., Lenz H.-J., Grp78 promoter polymorphism rs391957 as potential predictor for clinical outcome in gastric and colorectal cancer patients. Annals of Oncology 2011 22 11 2431 2439 2-s2.0-80155124379 10.1093/annonc/mdq771
79. Zhu X., Chen L., Fan W., Lin M. C. M., Tian L., Wang M., Lin S., Wang Z., Zhang J., Wang J., Yao H., Kung H., Li D., An intronic variant in the GRP78, a stress-associated gene, improves prediction for liver cirrhosis in persistent HBV carriers. PLoS ONE 2011 6 7 2-s2.0-79960292957 10.1371/journal.pone.0021997 e21997
80. Zhu X., Chen M.-S., Tian L.-W., Li D.-P., Xu P.-L., Lin M. C. M., Xie D., Kung H.-F., Single nucleotide polymorphism of rs430397 in the fifth intron of GRP78 gene and clinical relevance of primary hepatocellular carcinoma in Han Chinese: risk and prognosis. International Journal of Cancer 2009 125 6 1352 1357 2-s2.0-68249154796 10.1002/ijc.24487
81. Liu S., Li K., Li T., Association between promoter polymorphisms of the GRP78 gene and risk of type 2 diabetes in a Chinese han population. DNA and Cell Biology 2013 32 3 119 124 10.1089/dna.2012.1909
82. Merrick D. T., GRP78, intronic polymorphisms, and pharmacogenomics in non-small cell lung cancer. Chest 2012 141 6 1377 1378
83. Lau M. Y., Han H., Hu J., Ji C., Association of cyclin D and estrogen receptor α 36 with hepatocellular adenomas of female mice under chronic endoplasmic reticulum stress. Journal of Gastroenterology and Hepatology 2013 28 3 576 583
84. Han H., Hu J., Lau M. Y., Feng M., Petrovic L. M., Ji C., Altered methylation and expression of ER-associated degradation factors in long-term alcohol and constitutive ER stress-induced murine hepatic tumors. Frontiers in Genetics 2013 4, article 224
85. Giannelli G., Napoli N., Antonaci S., Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma. Current Pharmaceutical Design 2007 13 32 3301 3304 2-s2.0-36749094535 10.2174/138161207782360609 (Pubitemid 350201685)
86. Muntané J., De la Rosa A. J., Docobo F., García-Carbonero R., Padillo F. J., Targeting tyrosine kinase receptors in hepatocellular carcinoma. Current Cancer Drug Targets 2013 13 3 300 312
87. Bioulac-Sage P., Taouji S., Possenti L., Balabaud C., Hepatocellular adenoma subtypes: the impact of overweight and obesity. Liver International 2012 32 8 1217 1221 2-s2.0-84858418490 10.1111/j.1478-3231.2012.02786.x
88. Nault J.-C., Zucman-Rossi J., Genetics of hepatobiliary carcinogenesis. Seminars in Liver Disease 2011 31 2 173 187 2-s2.0-79955631558 10.1055/s-0031-1276646
89. Katabathina V. S., Menias C. O., Shanbhogue A. K. P., Jagirdar J., Paspulati R. M., Prasad S. R., Genetics and imaging of hepatocellular adenomas: 2011 update. Radiographics 2011 31 6 1529 1543 2-s2.0-84857436993
90. Lin H., Van Den Esschert J., Liu C., Van Gulik T. M., Systematic review of hepatocellular adenoma in China and other regions. Journal of Gastroenterology and Hepatology 2011 26 1 28 35 2-s2.0-78650378866 10.1111/j.1440-1746.2010.06502.x
91. Edmondson H. A., Henderson B., Benton B., Liver cell adenomas associated with use of oral contraceptives. The New England Journal of Medicine 1976 294 9 470 472 2-s2.0-0017253557
92. Bioulac-Sage P., Cubel G., Balabaud C., Zucman-Rossi J., Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers. Seminars in Liver Disease 2011 31 1 91 103 2-s2.0-79951924787 10.1055/s-0031-1272837
93. Guichard C., Amaddeo G., Imbeaud S., Ladeiro Y., Pelletier L., Maad I. B., Calderaro J., Bioulac-Sage P., Letexier M., Degos F., Clément B., Balabaud C., Chevet E., Laurent A., Couchy G., Letouzé E., Calvo F., Zucman-Rossi J., Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma. Nature Genetics 2012 44 694 698 2-s2.0-84860593675 10.1038/ng.2256
94. Brewer J. W., Hendershot L. M., Sherr C. J., Diehl J. A., Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression. Proceedings of the National Academy of Sciences of the United States of America 1999 96 15 8505 8510 2-s2.0-0033587675 10.1073/pnas.96.15.8505 (Pubitemid 29354821)
95. Brewer J. W., Diehl J. A., PERK mediates cell-cycle exit during the mammalian unfolded protein response. Proceedings of the National Academy of Sciences of the United States of America 2000 97 23 12625 12630 2-s2.0-0033739622 10.1073/pnas.220247197
96. Hamanaka R. B., Bennett B. S., Cullinan S. B., Diehl J. A., PERK and GCN2 contribute to eIF2 α phosphorylation and cell cycle arrest after activation of the unfolded protein response pathway. Molecular Biology of the Cell 2005 16 12 5493 5501 2-s2.0-28644441875 10.1091/mbc.E05-03-0268 (Pubitemid 41752201)
97. Kim J. K., Diehl J. A., Nuclear cyclin D1: an oncogenic driver in human cancer. Journal of Cellular Physiology 2009 220 2 292 296 2-s2.0-67649352637 10.1002/jcp.21791
98. Pestell R. G., New roles of cyclin D1. The American Journal of Pathology 2013 183 1 3 9
99. Musgrove E. A., Caldon C. E., Barraclough J., Stone A., Sutherland R. L., Cyclin D as a therapeutic target in cancer. Nature Reviews Cancer 2011 11 8 558 572 2-s2.0-79960836823 10.1038/nrc3090
100. Fu M., Wang C., Li Z., Sakamaki T., Pestell R. G., Minireview: cyclin D1: normal and abnormal functions. Endocrinology 2004 145 12 5439 5447 2-s2.0-9444236895 10.1210/en.2004-0959 (Pubitemid 39564581)
101. Oyama T., Kashiwabara K., Yoshimoto K., Arnold A., Koerner F., Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Research 1998 58 13 2876 2880 2-s2.0-0032126542 (Pubitemid 28311922)
102. Shoker B. S., Jarvis C., Davies M. P. A., Iqbal M., Sibson D. R., Sloane J. P., Immunodetectable cyclin D1 is associated with oestrogen receptor but not Ki67 in normal, cancerous and precancerous breast lesions. British Journal of Cancer 2001 84 8 1064 1069 2-s2.0-0035917617 10.1054/bjoc.2001.1705 (Pubitemid 32448503)
103. Ledda-Columbano G. M., Pibiri M., Concas D., Cossu C., Tripodi M., Columbano A., Loss of cyclin D1 does not inhibit the proliferative response of mouse liver to mitogenic stimuli. Hepatology 2002 36 5 1098 1105 2-s2.0-0036829767 10.1053/jhep.2002.36159 (Pubitemid 35253425)
104. Lu J. W., Lin Y. M., Chang J. G., Yeh K. T., Chen R. M., Tsai J. J., Su W. W., Hu R. M., Clinical implications of deregulated CDK4 and Cyclin D1 expression in patients with human hepatocellular carcinoma. Medical Oncology 2013 30 1, article 379
105. Suh J. H., Shenvi S. V., Dixon B. M., Liu H., Jaiswal A. K., Liu R.-M., Hagen T. M., Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid. Proceedings of the National Academy of Sciences of the United States of America 2004 101 10 3381 3386 2-s2.0-1542723493 10.1073/pnas.0400282101 (Pubitemid 38338203)
106. Zhang Y., Wang L., Nuclear receptor small heterodimer partner in apoptosis signaling and liver cancer. Cancers 2011 3 1 198 212 2-s2.0-79953702566 10.3390/cancers3010198
107. Zhang Y., Hagedorn C. H., Wang L., Role of nuclear receptor SHP in metabolism and cancer. Biochimica et Biophysica Acta 2011 1812 8 893 908 2-s2.0-79958243702 10.1016/j.bbadis.2010.10.006
108. Zhang W., Hietakangas V., Wee S., Lim S. C., Gunaratne J., Cohen S. M., ER stress potentiates insulin resistance through PERK-mediated FOXO phosphorylation. Genes & Development 2013 27 4 441 449
109. Czaja M. J., Ding W. X., Donohue T. M. Jr., Functions of autophagy in normal and diseased liver. Autophagy 2013 9 8 1131 1158
110. Tikhanovich I., Kuravi S., Campbell R. V., Kharbanda K. K., Artigues A., Villar M. T., Weinman S. A., Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure. Hepatology 2014 59 1 58 70
111. Kopycinska J., Kempińska-Podhorodecka A., Haas T., Elias E., DePinho R. A., Paik J., Milkiewicz P., Milkiewicz M., Activation of FoxO3a/Bim axis in patients with Primary Biliary Cirrhosis. Liver International 2013 33 2 231 238
112. Wu T., Zhao F., Gao B., Tan C., Yagishita N., Nakajima T., Wong P. K., Chapman E., Fang D., Zhang D. D., Hrd1 suppresses Nrf2-mediated cellular protection during liver cirrhosis. Genes & Development 2014 10.1101/gad.238246.114
113. Yan Z., Tan W., Dan Y., Zhao W., Deng C., Wang Y., Deng G., Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese population. BMC Medical Genetics 2012 13, article 49
114. Miceli V., Cocciadiferro L., Fregapane M., Zarcone M., Montalto G., Polito L. M., Agostara B., Granata O. M., Carruba G., Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. OMICS A Journal of Integrative Biology 2011 15 5 313 317 2-s2.0-79956088615 10.1089/omi.2010.0108
115. Quaynor S. D., Stradtman Jr E. W., Kim H. G., Shen Y., Chorich L. P., Schreihofer D. A., Layman L. C., Delayed puberty and estrogen resistance in a woman with estrogen receptor α variant. The New England Journal of Medicine 2013 369 2 164 171
116. Clegg D. J., Palmer B. F., Effects of an estrogen receptor α variant. The New England Journal of Medicine 2013 369 17 1663 1664
117. Moeini A., Cornellà H., Villanueva A., Emerging signaling pathways in hepatocellular carcinoma. Liver Cancer 2012 1 2 83 93
118. Vranic S., Gatalica Z., Deng H., Frkovic-Grazio S., Lee L. M. J., Gurjeva O., Wang Z.-Y., ER- α 36, a novel isoform of ER- α 66, is commonly over-expressed in apocrine and adenoid cystic carcinomas of the breast. Journal of Clinical Pathology 2011 64 1 54 57 2-s2.0-78650812797 10.1136/jcp.2010.082776
119. Chaudhri R. A., Olivares-Navarrete R., Cuenca N., Hadadi A., Boyan B. D., Schwartz Z., Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor- α 36 (ER α 36). Journal of Biological Chemistry 2012 287 10 7169 7181 2-s2.0-84857756831 10.1074/jbc.M111.292946
120. Wang J., Li J., Fang R., Xie S., Wang L., Xu C., Expression of ER α 36 in gastric cancer samples and their matched normal tissues. Oncology Letters 2012 3 1 172 175 2-s2.0-84855211437 10.3892/ol.2011.437
121. Zhang X. T., Ding L., Kang L. G., Wang Z. Y., Involvement of ER- α 36, Src, EGFR and STAT5 in the biphasic estrogen signaling of ER-negative breast cancer cells. Oncology Reports 2012 27 6 2057 2065
122. Chaudhri R. A., Olivares-Navarrete R., Cuenca N., Hadadi A., Boyan B. D., Schwartz Z., Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor- α 36 (ER α 36). Journal of Biological Chemistry 2012 287 10 7169 7181 2-s2.0-84857756831 10.1074/jbc.M111.292946
123. Di Maio M., Daniele B., Pignata S., Gallo C., De Maio E., Morabito A., Piccirillo M. C., Perrone F., IS human hepatocellular carcinoma a hormone-responsive tumor? World Journal of Gastroenterology 2008 14 11 1682 1689 2-s2.0-41849114144 10.3748/wjg.14.1682 (Pubitemid 351493374)
124. Center M. M., Jemal A., International trends in liver cancer incidence rates. Cancer Epidemiology Biomarkers and Prevention 2011 20 11 2362 2368 2-s2.0-81155126122 10.1158/1055-9965.EPI-11-0643
125. Venook A. P., Papandreou C., Furuse J., de Guevara L. L., The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. The Oncologist 2010 15 supplement 4 5 13 2-s2.0-79952277505